WealthSpring Partners’s iShares US Medical Devices ETF IHI Stock Holding History

WealthSpring Partners’s Portfolio IHI Stock Details IHI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$397K	Hold	8,039	–	–	0.34%	43
2026 Q1	$429K	Hold	8,039	–	–	0.39%	44
2025 Q4	$500K	Buy	+8,039	New	+$496K	0.51%	30
2023 Q3	$946K	Buy	19,512 +348	+2%	+$18.5K	0.71%	23
2023 Q2	$1.08M	Hold	19,164	–	–	0.78%	21
2023 Q1	$1.03M	Hold	19,164	–	–	0.8%	20
2022 Q4	$1.01M	Hold	19,164	–	–	0.79%	22
2022 Q3	$904K	Buy	+19,164	New	+$994K	0.8%	20

Other funds holding IHI

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

AAS

Annex Advisory Services Brookfield, Wisconsin $5.86B AUM 21.83% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return

WealthSpring Partners's IHI Position: Q2 2026 in Review

WealthSpring Partners held its iShares US Medical Devices ETF (IHI) position steady in Q2 2026 at 8,039 shares worth $397K. The position accounts for 0.34% of the portfolio, ranked #43.

WealthSpring Partners first reported a position in IHI in Q3 2022 and has held it in 8 quarters since. The position peaked at $1.08M in Q2 2023. 501 funds tracked by Wall St. Rank hold IHI as of Q2 2026.

WealthSpring Partners held 8,039 shares of iShares US Medical Devices ETF worth $397K as of Q2 2026.
WealthSpring Partners left its iShares US Medical Devices ETF share count unchanged in Q2 2026.
iShares US Medical Devices ETF made up 0.34% of WealthSpring Partners's portfolio in Q2 2026, its #43 holding.
WealthSpring Partners first reported a position in iShares US Medical Devices ETF in Q3 2022 and has held it in 8 quarters since.
WealthSpring Partners's iShares US Medical Devices ETF position peaked at $1.08M in Q2 2023.
501 funds tracked by Wall St. Rank held iShares US Medical Devices ETF as of Q2 2026.

Based on WealthSpring Partners's 13F filing for Q2 2026, filed 5 Aug 2026.